Physiomics PLC (GB:PYC)
LSE:PYC
Want to see GB:PYC full AI Analyst Report?
PYC Stock Chart & Stats
0.28 p
0.05 p(6.45%)
At close: 4:00 PM EST
0.28 p
0.05 p(6.45%)
Day’s Range― - ―
52-Week Range0.25 p - 0.80 p
Previous CloseN/A
Volume16.21M
Average Volume (3M)2.43M
Market Cap
£2.95M
Enterprise Value2.10M
Total Cash (Recent Filing)£257.00K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding453,208,700
10 Day Avg. Volume1,168,038
30 Day Avg. Volume2,434,740
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.60
Price to Sales (P/S)1.41
P/FCF Ratio-2.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low-debt Balance SheetA near-zero debt position and a modest equity cushion reduce refinancing and interest-rate risks, giving management flexibility to fund operations or pursue partnerships. This structural strength supports survivability and strategic optionality over the next several quarters.
Strong 2025 Revenue ReboundA ~51% revenue increase signals improving commercial traction for its modelling services, indicating growing client demand and scalability of project work. If sustained, this top-line momentum improves odds of fixed-cost absorption and eventual margin recovery.
Specialized Fee-for-service Business ModelA consultancy/platform mix focused on QSP and mechanistic modelling creates high-value, repeatable engagements with pharma customers. Specialized expertise raises switching costs and supports long-term client relationships and recurring project pipelines.
Bears Say
Persistent LossesOngoing net losses and deeply negative margins indicate the business has not reached structural profitability. Continued losses over multiple periods risk depleting equity, constrain reinvestment, and necessitate external capital unless margins materially improve.
Recurring Cash BurnNegative operating and free cash flow show the company is not self-funding its growth. This persistent cash burn elevates the need for additional financing or equity raises, creating dilution or funding-risk considerations that constrain long-term investment plans.
Very Low/negative Returns On EquityA roughly -60% ROE signals ongoing value destruction; with a small equity base (~£0.69M), continued losses can quickly erode shareholder capital. This raises the likelihood of capital raises and dilution, reducing long-term shareholder upside if unaddressed.
Physiomics News
PYC FAQ
What was Physiomics PLC’s price range in the past 12 months?
Physiomics PLC lowest share price was 0.25 p and its highest was 0.80 p in the past 12 months.
What is Physiomics PLC’s market cap?
Physiomics PLC’s market cap is £2.95M.
When is Physiomics PLC’s upcoming earnings report date?
Physiomics PLC’s upcoming earnings report date is Sep 24, 2026 which is in 110 days.
How were Physiomics PLC’s earnings last quarter?
Physiomics PLC released its earnings results on Feb 16, 2026. The company reported -0.001 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001 p.
Is Physiomics PLC overvalued?
According to Wall Street analysts Physiomics PLC’s price is currently Overvalued.
Does Physiomics PLC pay dividends?
Physiomics PLC does not currently pay dividends.
What is Physiomics PLC’s EPS estimate?
Physiomics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Physiomics PLC have?
Physiomics PLC has 453,208,700 shares outstanding.
What happened to Physiomics PLC’s price movement after its last earnings report?
Physiomics PLC reported an EPS of -0.001 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -15.385%.
Which hedge fund is a major shareholder of Physiomics PLC?
Currently, no hedge funds are holding shares in GB:PYC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Physiomics PLC
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.